Epigenetics and beyond: targeting writers of protein lysine methylation to treat disease
出版年份 2021 全文链接
标题
Epigenetics and beyond: targeting writers of protein lysine methylation to treat disease
作者
关键词
-
出版物
NATURE REVIEWS DRUG DISCOVERY
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2021-01-19
DOI
10.1038/s41573-020-00108-x
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Phase 2 Multicenter Study of Tazemetostat, an EZH2 Inhibitor, in Patients with Relapsed or Refractory Follicular Lymphoma
- (2020) Franck Morschhauser et al. BLOOD
- SETD5-Coordinated Chromatin Reprogramming Regulates Adaptive Resistance to Targeted Pancreatic Cancer Therapy
- (2020) Zhentian Wang et al. CANCER CELL
- Epigenetic Therapy for Epithelioid Sarcoma
- (2020) Scott B. Rothbart et al. CELL
- Blocking immunosuppressive neutrophils deters pY696-EZH2–driven brain metastases
- (2020) Lin Zhang et al. Science Translational Medicine
- Gain-of-function genetic alterations of G9a drive oncogenesis
- (2020) Shinichiro Kato et al. Cancer Discovery
- Downregulation of histone methyltransferase SET8 inhibits progression of hepatocellular carcinoma
- (2020) Jianhua Wu et al. Scientific Reports
- Epigenetic mechanism of SETDB1 in brain: implications for neuropsychiatric disorders
- (2020) Yueyan Zhu et al. Translational Psychiatry
- The complex role of EZH2 in the tumor microenvironment: opportunities and challenges for immunotherapy combinations
- (2020) Jing Qiu et al. Future Medicinal Chemistry
- METTL13 Methylation of eEF1A Increases Translational Output to Promote Tumorigenesis
- (2019) Shuo Liu et al. CELL
- Immunologic correlates of the abscopal effect in a SMARCB1/INI1-negative Poorly Differentiated Chordoma after EZH2 inhibition and radiotherapy
- (2019) Mrinal M. Gounder et al. CLINICAL CANCER RESEARCH
- Structural Basis for Recognition of Ubiquitylated Nucleosome by Dot1L Methyltransferase
- (2019) Cathy J. Anderson et al. Cell Reports
- Epigenetic therapy of Prader–Willi syndrome
- (2019) Yuna Kim et al. Translational Research
- Contrasting requirements during disease evolution identify EZH2 as a therapeutic target in AML
- (2019) Faisal Basheer et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Structural basis of recognition and destabilization of the histone H2B ubiquitinated nucleosome by the DOT1L histone H3 Lys79 methyltransferase
- (2019) Seongmin Jang et al. GENES & DEVELOPMENT
- EZH2 cooperates with gain‐of‐function p53 mutants to promote cancer growth and metastasis
- (2019) Yu Zhao et al. EMBO JOURNAL
- Structural basis of the crosstalk between histone H2B monoubiquitination and H3 lysine 79 methylation on nucleosome
- (2019) Tonghui Yao et al. CELL RESEARCH
- Mechanism of Cross-talk between H2B Ubiquitination and H3 Methylation by Dot1L
- (2019) Evan J. Worden et al. CELL
- Structural Basis of Dot1L Stimulation by Histone H2B Lysine 120 Ubiquitination
- (2019) Marco Igor Valencia-Sánchez et al. MOLECULAR CELL
- KMT9 monomethylates histone H4 lysine 12 and controls proliferation of prostate cancer cells
- (2019) Eric Metzger et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Discovery of Irreversible Inhibitors Targeting Histone Methyltransferase, SMYD3
- (2019) Chuhui Huang et al. ACS Medicinal Chemistry Letters
- Functional diversity of inhibitors tackling the differentiation blockage of MLL-rearranged leukemia
- (2019) Krzysztof Brzezinka et al. Journal of Hematology & Oncology
- Fragment-based discovery of a chemical probe for the PWWP1 domain of NSD3
- (2019) Jark Böttcher et al. Nature Chemical Biology
- DOT1L inhibition reveals a distinct subset of enhancers dependent on H3K79 methylation
- (2019) Laura Godfrey et al. Nature Communications
- Unveiling the Biochemistry of the Epigenetic Regulator SMYD3
- (2019) Edoardo Fabini et al. BIOCHEMISTRY
- Phase 1 study of the novel enhancer of zeste homolog 2 (EZH2) inhibitor GSK2816126 in patients with advanced hematological and solid tumors
- (2019) Timothy A. Yap et al. CLINICAL CANCER RESEARCH
- Targeting EZH2 enhances antigen presentation, antitumor immunity and circumvents anti-PD-1 resistance in head and neck cancers
- (2019) Liye Zhou et al. CLINICAL CANCER RESEARCH
- Automethylation of PRC2 promotes H3K27 methylation and is impaired in H3K27M pediatric glioma
- (2019) Chul-Hwan Lee et al. GENES & DEVELOPMENT
- Regulation of histone methylation by automethylation of PRC2
- (2019) Xueyin Wang et al. GENES & DEVELOPMENT
- Lysine Methylation Regulators Moonlighting outside the Epigenome
- (2019) Evan M. Cornett et al. MOLECULAR CELL
- SETD5 Regulates Chromatin Methylation State and Preserves Global Transcriptional Fidelity during Brain Development and Neuronal Wiring
- (2019) Alessandro Sessa et al. NEURON
- Inhibition of DOT1L and PRMT5 promote synergistic anti-tumor activity in a human MLL leukemia model induced by CRISPR/Cas9
- (2019) Kathy-Ann Secker et al. ONCOGENE
- Human HemK2/KMT9/N6AMT1 is an active protein methyltransferase, but does not act on DNA in vitro, in the presence of Trm112
- (2019) Clayton B. Woodcock et al. Cell Discovery
- A Phase Ib/II Study of the Histone Methyltransferase Inhibitor Pinometostat in Combination with Azacitidine in Patients with 11q23-Rearranged Acute Myeloid Leukemia
- (2019) Kamal Menghrajani et al. BLOOD
- Histone lysine methyltransferases in biology and disease
- (2019) Dylan Husmann et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Targeting Excessive EZH1 and EZH2 Activities for Abnormal Histone Methylation and Transcription Network in Malignant Lymphomas
- (2019) Makoto Yamagishi et al. Cell Reports
- Histone methyltransferases EHMT1 and EHMT2 (GLP/G9A) maintain PARP inhibitor resistance in high-grade serous ovarian carcinoma
- (2019) Zachary L. Watson et al. Clinical Epigenetics
- EZH2 negatively regulates PD-L1 expression in hepatocellular carcinoma
- (2019) Gang Xiao et al. Journal for ImmunoTherapy of Cancer
- H2A.Z facilitates licensing and activation of early replication origins
- (2019) Haizhen Long et al. NATURE
- Discovery of a first-in-class EZH2 selective degrader
- (2019) Anqi Ma et al. Nature Chemical Biology
- Discovery of a chemical probe for PRDM9
- (2019) Abdellah Allali-Hassani et al. Nature Communications
- The DOT1L inhibitor pinometostat reduces H3K79 methylation and has modest clinical activity in adult acute leukemia
- (2018) Eytan M. Stein et al. BLOOD
- Identification of Rpl29 as a major substrate of the lysine methyltransferase Set7/9
- (2018) Tewfik Hamidi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Complexity of Blocking Bivalent Protein–Protein Interactions: Development of a Highly Potent Inhibitor of the Menin–Mixed-Lineage Leukemia Interaction
- (2018) Dmitry Borkin et al. JOURNAL OF MEDICINAL CHEMISTRY
- Small molecule inhibitors and CRISPR/Cas9 mutagenesis demonstrate that SMYD2 and SMYD3 activity are dispensable for autonomous cancer cell proliferation
- (2018) Michael J. Thomenius et al. PLoS One
- Regulation of eukaryotic elongation factor 1 alpha (eEF1A) by dynamic lysine methylation
- (2018) Magnus E. Jakobsson et al. RNA Biology
- Structures of human PRC2 with its cofactors AEBP2 and JARID2
- (2018) Vignesh Kasinath et al. SCIENCE
- Translational Control in Cancer
- (2018) Nathaniel Robichaud et al. Cold Spring Harbor Perspectives in Biology
- MLL-fusion-driven leukemia requires SETD2 to safeguard genomic integrity
- (2018) Anna Skucha et al. Nature Communications
- Modulation of EZH2 expression in T cells improves efficacy of anti–CTLA-4 therapy
- (2018) Sangeeta Goswami et al. JOURNAL OF CLINICAL INVESTIGATION
- Phase 2, multicenter study of the EZH2 inhibitor tazemetostat as monotherapy in adults with relapsed or refractory (R/R) malignant mesothelioma (MM) with BAP1 inactivation.
- (2018) Marjorie Glass Zauderer et al. JOURNAL OF CLINICAL ONCOLOGY
- MYC Interacts with the G9a Histone Methyltransferase to Drive Transcriptional Repression and Tumorigenesis
- (2018) William B. Tu et al. CANCER CELL
- Aberrant PRDM9 expression impacts the pan-cancer genomic landscape
- (2018) Armande Ang Houle et al. GENOME RESEARCH
- SETD3 is an actin histidine methyltransferase that prevents primary dystocia
- (2018) Alex W. Wilkinson et al. NATURE
- Loss of G9a preserves mutation patterns but increases chromatin accessibility, genomic instability and aggressiveness in skin tumours
- (2018) Alexandra Avgustinova et al. NATURE CELL BIOLOGY
- Knockdown of the histone di-methyltransferase G9a in nucleus accumbens shell decreases cocaine self-administration, stress-induced reinstatement, and anxiety
- (2018) Ethan M. Anderson et al. NEUROPSYCHOPHARMACOLOGY
- H3K9 methyltransferases and demethylases control lung tumor-propagating cells and lung cancer progression
- (2018) S. P. Rowbotham et al. Nature Communications
- Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator
- (2018) Jung Kim et al. Cell Reports
- SETD3 protein is the actin-specific histidine N-methyltransferase
- (2018) Sebastian Kwiatkowski et al. eLife
- Discovery of Potent and Selective Inhibitors for G9a-Like Protein (GLP) Lysine Methyltransferase
- (2017) Yan Xiong et al. JOURNAL OF MEDICINAL CHEMISTRY
- The MLL recombinome of acute leukemias in 2017
- (2017) C Meyer et al. LEUKEMIA
- Polycomb Repressive Complex 2 Methylates Elongin A to Regulate Transcription
- (2017) M. Behfar Ardehali et al. MOLECULAR CELL
- SnapShot: Lysine Methylation beyond Histones
- (2017) Kyle K. Biggar et al. MOLECULAR CELL
- Methylation of DNA Ligase 1 by G9a/GLP Recruits UHRF1 to Replicating DNA and Regulates DNA Methylation
- (2017) Laure Ferry et al. MOLECULAR CELL
- Transcription control by the ENL YEATS domain in acute leukaemia
- (2017) Michael A. Erb et al. NATURE
- ENL links histone acetylation to oncogenic gene expression in acute myeloid leukaemia
- (2017) Liling Wan et al. NATURE
- Promoter-bound METTL3 maintains myeloid leukaemia by m6A-dependent translation control
- (2017) Isaia Barbieri et al. NATURE
- An allosteric PRC2 inhibitor targeting the H3K27me3 binding pocket of EED
- (2017) Wei Qi et al. Nature Chemical Biology
- The EED protein–protein interaction inhibitor A-395 inactivates the PRC2 complex
- (2017) Yupeng He et al. Nature Chemical Biology
- The SUV4-20 inhibitor A-196 verifies a role for epigenetics in genomic integrity
- (2017) Kenneth D Bromberg et al. Nature Chemical Biology
- EZH2 is a potential therapeutic target for H3K27M-mutant pediatric gliomas
- (2017) Faizaan Mohammad et al. NATURE MEDICINE
- Therapeutic targeting of polycomb and BET bromodomain proteins in diffuse intrinsic pontine gliomas
- (2017) Andrea Piunti et al. NATURE MEDICINE
- Marked for death: targeting epigenetic changes in cancer
- (2017) Sophia Xiao Pfister et al. NATURE REVIEWS DRUG DISCOVERY
- Methylation of human eukaryotic elongation factor alpha (eEF1A) by a member of a novel protein lysine methyltransferase family modulates mRNA translation
- (2017) Magnus E. Jakobsson et al. NUCLEIC ACIDS RESEARCH
- The Histone Methyltransferase Ezh2 Controls Mechanisms of Adaptive Resistance to Tumor Immunotherapy
- (2017) Daniel Zingg et al. Cell Reports
- Mixed-Lineage Leukemia Fusions and Chromatin in Leukemia
- (2017) Andrei V. Krivtsov et al. Cold Spring Harbor Perspectives in Medicine
- The Role of Nuclear Receptor–Binding SET Domain Family Histone Lysine Methyltransferases in Cancer
- (2017) Richard L. Bennett et al. Cold Spring Harbor Perspectives in Medicine
- Protein lysine methylation by seven- -strand methyltransferases
- (2016) P. O. Falnes et al. BIOCHEMICAL JOURNAL
- DOT1L as a therapeutic target for the treatment of DNMT3A -mutant acute myeloid leukemia
- (2016) Rachel E. Rau et al. BLOOD
- Smyd3 Is a Transcriptional Potentiator of Multiple Cancer-Promoting Genes and Required for Liver and Colon Cancer Development
- (2016) Michalis E. Sarris et al. CANCER CELL
- SETDB2 Links Glucocorticoid to Lipid Metabolism through Insig2a Regulation
- (2016) Manuel Roqueta-Rivera et al. Cell Metabolism
- The upstreams and downstreams of H3K79 methylation by DOT1L
- (2016) Hanneke Vlaming et al. CHROMOSOMA
- The role of PRDMs in cancer: one family, two sides
- (2016) Slim Mzoughi et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
- Coordination of stress signals by the lysine methyltransferase SMYD2 promotes pancreatic cancer
- (2016) Nicolas Reynoird et al. GENES & DEVELOPMENT
- Molecular basis for oncohistone H3 recognition by SETD2 methyltransferase
- (2016) Shuang Yang et al. GENES & DEVELOPMENT
- Substrate Specificity of the HEMK2 Protein Glutamine Methyltransferase and Identification of Novel Substrates
- (2016) Denis Kusevic et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Design, Synthesis, and Biological Activity of Substrate Competitive SMYD2 Inhibitors
- (2016) Scott D. Cowen et al. JOURNAL OF MEDICINAL CHEMISTRY
- Identification of (R)-N-((4-Methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1H-indole-3-carboxamide (CPI-1205), a Potent and Selective Inhibitor of Histone Methyltransferase EZH2, Suitable for Phase I Clinical Trials for B-Cell Lymphomas
- (2016) Rishi G. Vaswani et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery and Characterization of a Highly Potent and Selective Aminopyrazoline-Based in Vivo Probe (BAY-598) for the Protein Lysine Methyltransferase SMYD2
- (2016) Erik Eggert et al. JOURNAL OF MEDICINAL CHEMISTRY
- Structure–Activity Relationship Studies for Enhancer of Zeste Homologue 2 (EZH2) and Enhancer of Zeste Homologue 1 (EZH1) Inhibitors
- (2016) Xiaobao Yang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Design and Synthesis of Pyridone-Containing 3,4-Dihydroisoquinoline-1(2H)-ones as a Novel Class of Enhancer of Zeste Homolog 2 (EZH2) Inhibitors
- (2016) Pei-Pei Kung et al. JOURNAL OF MEDICINAL CHEMISTRY
- Structure-Based Design of a Covalent Inhibitor of the SET Domain-Containing Protein 8 (SETD8) Lysine Methyltransferase
- (2016) Kyle V. Butler et al. JOURNAL OF MEDICINAL CHEMISTRY
- Quantitative Profiling of the Activity of Protein Lysine Methyltransferase SMYD2 Using SILAC-Based Proteomics
- (2016) Jonathan B. Olsen et al. MOLECULAR & CELLULAR PROTEOMICS
- Insights into newly discovered marks and readers of epigenetic information
- (2016) Forest H Andrews et al. Nature Chemical Biology
- Targeting EZH2 in cancer
- (2016) Kimberly H Kim et al. NATURE MEDICINE
- The Human Mixed Lineage Leukemia 5 (MLL5), a Sequentially and Structurally Divergent SET Domain-Containing Protein with No Intrinsic Catalytic Activity
- (2016) Sarah Mas-y-Mas et al. PLoS One
- Structure-Based Design of a Novel SMYD3 Inhibitor that Bridges the SAM-and MEKK2-Binding Pockets
- (2016) Glenn S. Van Aller et al. STRUCTURE
- Optimization of a Fragment-Based Screening Hit toward Potent DOT1L Inhibitors Interacting in an Induced Binding Pocket
- (2016) Clemens Scheufler et al. ACS Medicinal Chemistry Letters
- Discovery of Novel Dot1L Inhibitors through a Structure-Based Fragmentation Approach
- (2016) Chao Chen et al. ACS Medicinal Chemistry Letters
- Structural basis of oncogenic histone H3K27M inhibition of human polycomb repressive complex 2
- (2016) Neil Justin et al. Nature Communications
- Polycomb repressive complex 2 structure with inhibitor reveals a mechanism of activation and drug resistance
- (2016) Alexei Brooun et al. Nature Communications
- Smyd2 is a Myc-regulated gene critical for MLL-AF9 induced leukemogenesis
- (2016) Sevgi Bagislar et al. Oncotarget
- The Meiotic Recombination Activator PRDM9 Trimethylates Both H3K36 and H3K4 at Recombination Hotspots In Vivo
- (2016) Natalie R. Powers et al. PLoS Genetics
- The emerging role of lysine methyltransferase SETD8 in human diseases
- (2016) Ciro Milite et al. Clinical Epigenetics
- Pharmacologic Inhibition of the Menin-MLL Interaction Blocks Progression of MLL Leukemia In Vivo
- (2015) Dmitry Borkin et al. CANCER CELL
- Interrogating the Function of Metazoan Histones using Engineered Gene Clusters
- (2015) Daniel J. McKay et al. DEVELOPMENTAL CELL
- Recognition of H3K9 methylation by GLP is required for efficient establishment of H3K9 methylation, rapid target gene repression, and mouse viability
- (2015) Nan Liu et al. GENES & DEVELOPMENT
- Up-regulation of histone methyltransferase SETDB1 by multiple mechanisms in hepatocellular carcinoma promotes cancer metastasis
- (2015) Chun-Ming Wong et al. HEPATOLOGY
- LLY-507, a Cell-active, Potent, and Selective Inhibitor of Protein-lysine Methyltransferase SMYD2
- (2015) Hannah Nguyen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Histone H4 Lysine 20 (H4K20) Methylation, Expanding the Signaling Potential of the Proteome One Methyl Moiety at a Time
- (2015) Rick van Nuland et al. MOLECULAR & CELLULAR PROTEOMICS
- The PZP Domain of AF10 Senses Unmodified H3K27 to Regulate DOT1L-Mediated Methylation of H3K79
- (2015) Shoudeng Chen et al. MOLECULAR CELL
- SWI/SNF-mutant cancers depend on catalytic and non-catalytic activity of EZH2
- (2015) Kimberly H Kim et al. NATURE MEDICINE
- Synthetic lethality by targeting EZH2 methyltransferase activity in ARID1A-mutated cancers
- (2015) Benjamin G Bitler et al. NATURE MEDICINE
- Structural basis of histone H3K27 trimethylation by an active polycomb repressive complex 2
- (2015) L. Jiao et al. SCIENCE
- Discovery of A-893, A New Cell-Active Benzoxazinone Inhibitor of Lysine Methyltransferase SMYD2
- (2015) Ramzi F. Sweis et al. ACS Medicinal Chemistry Letters
- Novel Oxindole Sulfonamides and Sulfamides: EPZ031686, the First Orally Bioavailable Small Molecule SMYD3 Inhibitor
- (2015) Lorna H. Mitchell et al. ACS Medicinal Chemistry Letters
- Small-Molecule Inhibitors of SETD8 with Cellular Activity
- (2014) Gil Blum et al. ACS Chemical Biology
- Histone methyltransferase SETDB1 is required for prostate cancer cell proliferation, migration and invasion
- (2014) Ying-Hao Sun et al. ASIAN JOURNAL OF ANDROLOGY
- Elongation factor methyltransferase 3 – A novel eukaryotic lysine methyltransferase
- (2014) Lelin Zhang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Selective inhibition of EZH2 and EZH1 enzymatic activity by a small molecule suppresses MLL-rearranged leukemia
- (2014) B. Xu et al. BLOOD
- Overexpression of SMYD2 contributes to malignant outcome in gastric cancer
- (2014) S Komatsu et al. BRITISH JOURNAL OF CANCER
- AF10 Regulates Progressive H3K79 Methylation and HOX Gene Expression in Diverse AML Subtypes
- (2014) Aniruddha J. Deshpande et al. CANCER CELL
- AF9 YEATS Domain Links Histone Acetylation to DOT1L-Mediated H3K79 Methylation
- (2014) Yuanyuan Li et al. CELL
- Identification and Characterization of a Novel Evolutionarily Conserved Lysine-specific Methyltransferase Targeting Eukaryotic Translation Elongation Factor 2 (eEF2)
- (2014) Erna Davydova et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Discovery of a Selective, Substrate-Competitive Inhibitor of the Lysine Methyltransferase SETD8
- (2014) Anqi Ma et al. JOURNAL OF MEDICINAL CHEMISTRY
- Selective Inhibitors of Protein Methyltransferases
- (2014) H. Ümit Kaniskan et al. JOURNAL OF MEDICINAL CHEMISTRY
- SMYD3 links lysine methylation of MAP3K2 to Ras-driven cancer
- (2014) Pawel K. Mazur et al. NATURE
- (R)-PFI-2 is a potent and selective inhibitor of SETD7 methyltransferase activity in cells
- (2014) D. Barsyte-Lovejoy et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Structure–activity relationship studies of SETD8 inhibitors
- (2014) Anqi Ma et al. MedChemComm
- Discovery and Development of Potent and Selective Inhibitors of Histone Methyltransferase G9a
- (2014) Ramzi F. Sweis et al. ACS Medicinal Chemistry Letters
- An Orally Bioavailable Chemical Probe of the Lysine Methyltransferases EZH2 and EZH1
- (2013) Kyle D. Konze et al. ACS Chemical Biology
- Potent inhibition of DOT1L as treatment of MLL-fusion leukemia
- (2013) S. R. Daigle et al. BLOOD
- Leukemic transformation by the MLL-AF6 fusion oncogene requires the H3K79 methyltransferase Dot1l
- (2013) A. J. Deshpande et al. BLOOD
- EZH2 mutations are frequent and represent an early event in follicular lymphoma
- (2013) C. Bodor et al. BLOOD
- Discovery of an in Vivo Chemical Probe of the Lysine Methyltransferases G9a and GLP
- (2013) Feng Liu et al. JOURNAL OF MEDICINAL CHEMISTRY
- Targeted disruption of the EZH2–EED complex inhibits EZH2-dependent cancer
- (2013) Woojin Kim et al. Nature Chemical Biology
- A METTL3–METTL14 complex mediates mammalian nuclear RNA N6-adenosine methylation
- (2013) Jianzhao Liu et al. Nature Chemical Biology
- A novel route to product specificity in the Suv4-20 family of histone H4K20 methyltransferases
- (2013) Stacey M. Southall et al. NUCLEIC ACIDS RESEARCH
- Durable tumor regression in genetically altered malignant rhabdoid tumors by inhibition of methyltransferase EZH2
- (2013) S. K. Knutson et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Inhibition of PRC2 Activity by a Gain-of-Function H3 Mutation Found in Pediatric Glioblastoma
- (2013) P. W. Lewis et al. SCIENCE
- Molecular Basis for the Regulation of the H3K4 Methyltransferase Activity of PRDM9
- (2013) Hong Wu et al. Cell Reports
- The SET8 H4K20 protein lysine methyltransferase has a long recognition sequence covering seven amino acid residues
- (2012) Srikanth Kudithipudi et al. BIOCHIMIE
- Conformational Adaptation Drives Potent, Selective and Durable Inhibition of the Human Protein Methyltransferase DOT1L
- (2012) Aravind Basavapathruni et al. Chemical Biology & Drug Design
- Smyd3 regulates cancer cell phenotypes and catalyzes histone H4 lysine 5 methylation
- (2012) Glenn S. Van Aller et al. Epigenetics
- A687V EZH2 is a gain-of-function mutation found in lymphoma patients
- (2012) Christina R. Majer et al. FEBS LETTERS
- G9a interacts with Snail and is critical for Snail-mediated E-cadherin repression in human breast cancer
- (2012) Chenfang Dong et al. JOURNAL OF CLINICAL INVESTIGATION
- Abrogation of MLL–AF10 and CALM–AF10-mediated transformation through genetic inactivation or pharmacological inhibition of the H3K79 methyltransferase Dot1l
- (2012) L Chen et al. LEUKEMIA
- The BAH domain of ORC1 links H4K20me2 to DNA replication licensing and Meier–Gorlin syndrome
- (2012) Alex J. Kuo et al. NATURE
- EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations
- (2012) Michael T. McCabe et al. NATURE
- A selective inhibitor of EZH2 blocks H3K27 methylation and kills mutant lymphoma cells
- (2012) Sarah K Knutson et al. Nature Chemical Biology
- Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas
- (2012) Gang Wu et al. NATURE GENETICS
- Mutation of A677 in histone methyltransferase EZH2 in human B-cell lymphoma promotes hypertrimethylation of histone H3 on lysine 27 (H3K27)
- (2012) M. T. McCabe et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Molecular architecture of human polycomb repressive complex 2
- (2012) Claudio Ciferri et al. eLife
- Nonsense Mutation and Inactivation of SMARCA4 (BRG1) in an Atypical Teratoid/Rhabdoid Tumor Showing Retained SMARCB1 (INI1) Expression
- (2011) Martin Hasselblatt et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- DOT1L, the H3K79 methyltransferase, is required for MLL-AF9-mediated leukemogenesis
- (2011) A. T. Nguyen et al. BLOOD
- Selective Killing of Mixed Lineage Leukemia Cells by a Potent Small-Molecule DOT1L Inhibitor
- (2011) Scott R. Daigle et al. CANCER CELL
- MLL-Rearranged Leukemia Is Dependent on Aberrant H3K79 Methylation by DOT1L
- (2011) Kathrin M. Bernt et al. CANCER CELL
- EZH2 Y641 mutations in follicular lymphoma
- (2011) C Bödör et al. LEUKEMIA
- p53-Dependent Transcription and Tumor Suppression Are Not Affected in Set7/9-Deficient Mice
- (2011) Bernhard Lehnertz et al. MOLECULAR CELL
- NSD2 Links Dimethylation of Histone H3 at Lysine 36 to Oncogenic Programming
- (2011) Alex J. Kuo et al. MOLECULAR CELL
- A chemical probe selectively inhibits G9a and GLP methyltransferase activity in cells
- (2011) Masoud Vedadi et al. Nature Chemical Biology
- Structural Basis of Substrate Methylation and Inhibition of SMYD2
- (2011) Andrew D. Ferguson et al. STRUCTURE
- Philadelphia Chromosome Symposium: commemoration of the 50th anniversary of the discovery of the Ph chromosome
- (2011) H. Sharat Chandra et al. Cancer Genetics
- Somatic mutations at EZH2 Y641 act dominantly through a mechanism of selectively altered PRC2 catalytic activity, to increase H3K27 trimethylation
- (2010) D. B. Yap et al. BLOOD
- Epigenetic Antagonism between Polycomb and SWI/SNF Complexes during Oncogenic Transformation
- (2010) Boris G. Wilson et al. CANCER CELL
- Linking H3K79 trimethylation to Wnt signaling through a novel Dot1-containing complex (DotCom)
- (2010) M. Mohan et al. GENES & DEVELOPMENT
- Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin
- (2010) Ryan D Morin et al. NATURE GENETICS
- Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders
- (2010) Thomas Ernst et al. NATURE GENETICS
- Binding of different histone marks differentially regulates the activity and specificity of polycomb repressive complex 2 (PRC2)
- (2010) C. Xu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Coordinated activities of wild-type plus mutant EZH2 drive tumor-associated hypertrimethylation of lysine 27 on histone H3 (H3K27) in human B-cell lymphomas
- (2010) C. J. Sneeringer et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Essential Role of the Histone Methyltransferase G9a in Cocaine-Induced Plasticity
- (2010) I. Maze et al. SCIENCE
- Structure–Activity Analysis of Semisynthetic Nucleosomes: Mechanistic Insights into the Stimulation of Dot1L by Ubiquitylated Histone H2B
- (2009) Robert K. McGinty et al. ACS Chemical Biology
- Phosphorylase and the origin of reversible protein phosphorylation
- (2009) Edmond H. Fischer BIOLOGICAL CHEMISTRY
- Overexpression of SMYD2 relates to tumor cell proliferation and malignant outcome of esophageal squamous cell carcinoma
- (2009) Shuhei Komatsu et al. CARCINOGENESIS
- The Target of the NSD Family of Histone Lysine Methyltransferases Depends on the Nature of the Substrate
- (2009) Yan Li et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Monomethylation of Histone H4-Lysine 20 Is Involved in Chromosome Structure and Stability and Is Essential for Mouse Development
- (2009) H. Oda et al. MOLECULAR AND CELLULAR BIOLOGY
- Role of the polycomb protein EED in the propagation of repressive histone marks
- (2009) Raphael Margueron et al. NATURE
- Somatic mutations of the histone H3K27 demethylase gene UTX in human cancer
- (2009) Gijs van Haaften et al. NATURE GENETICS
- Structural basis for G9a-like protein lysine methyltransferase inhibition by BIX-01294
- (2009) Yanqi Chang et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- H3K79 Methylation Profiles Define Murine and Human MLL-AF4 Leukemias
- (2008) Andrei V. Krivtsov et al. CANCER CELL
- PR-SET7 and SUV4-20H regulate H4 lysine-20 methylation at imprinting control regions in the mouse
- (2008) Maëlle Pannetier et al. EMBO REPORTS
- HemK2 protein, encoded on human chromosome 21, methylates translation termination factor eRF1
- (2008) Sabine Figaro et al. FEBS LETTERS
- A chromatin-wide transition to H4K20 monomethylation impairs genome integrity and programmed DNA rearrangements in the mouse
- (2008) G. Schotta et al. GENES & DEVELOPMENT
- Preferential Dimethylation of Histone H4 Lysine 20 by Suv4-20
- (2008) Hongbo Yang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Ezh1 and Ezh2 Maintain Repressive Chromatin through Different Mechanisms
- (2008) Raphael Margueron et al. MOLECULAR CELL
- Chemically ubiquitylated histone H2B stimulates hDot1L-mediated intranucleosomal methylation
- (2008) Robert K. McGinty et al. NATURE
- A model for transmission of the H3K27me3 epigenetic mark
- (2008) Klaus H. Hansen et al. NATURE CELL BIOLOGY
- The effect of H3K79 dimethylation and H4K20 trimethylation on nucleosome and chromatin structure
- (2008) Xu Lu et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- The ankyrin repeats of G9a and GLP histone methyltransferases are mono- and dimethyllysine binding modules
- (2008) Robert E Collins et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- The Histone H3K79 Methyltransferase Dot1L Is Essential for Mammalian Development and Heterochromatin Structure
- (2008) Brendan Jones et al. PLoS Genetics
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started